Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:00 pm Sale | 13G | BIONOMICS LTD ADS BNOX | TANG CAPITAL PARTNERS LP | 0 0% | -126,000,000 (Position Closed) | View |
| 2024-02-14 10:20 am Sale | 13G | BIONOMICS LTD ADS BNOX | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -170,089,885 (Position Closed) | View |
| 2024-02-14 09:18 am Sale | 13G | BIONOMICS LTD ADS BNOX | Lynx1 Capital Management LP | 148,374,900 7.8% | -6,400,800 (-4.14%) | View |
| 2024-02-14 06:45 am Sale | 13G | BIONOMICS LTD ADS BNOX | Point72 Asset Management L.P. | 59,580,000 4% | -59,512,680 (-49.97%) | View |
| 2023-10-30 4:21 pm Purchase | 13G | BIONOMICS LTD ADS BNOX | Lynx1 Capital Management LP | 154,775,700 8.2% | 154,775,700 (New Position) | View |
| 2023-10-10 4:00 pm Purchase | 13G | BIONOMICS LTD ADS BNOX | TANG CAPITAL PARTNERS LP | 126,000,000 8.6% | 126,000,000 (New Position) | View |
| 2023-09-29 4:33 pm Purchase | 13G | BIONOMICS LTD ADS BNOX | Point72 Asset Management L.P. | 119,092,680 8.1% | 119,092,680 (New Position) | View |
| 2022-02-14 12:56 pm Purchase | 13G | BIONOMICS LTD ADS BNOX | BIOTECHNOLOGY VALUE FUND L P | 170,089,885 13% | 170,089,885 (New Position) | View |
| 2021-12-30 4:31 pm Purchase | 13D | BIONOMICS LTD ADS BNOX | Apeiron Investment Group Ltd. | 402,550,387 27.7% | 402,550,387 (New Position) | View |